Gilboa Therapeutics Israeli Company

Gilboa Therapeutics is a preclinical-stage cancer immunotherapy company with a mission to dramatically improve outcomes and save lives. The company is focused on the development of SolidT, a next-generation cell therapy designed to harness the power of a patients own immune system to treat a wide range of cancers.